Medicines from France warned that the coronavirus could cause the development of thyroid diseases, both of both inflammatory and autoimuminous nature. About the unexpected consequence of COVID-19 report “Izvestia” with reference to the study of specialists from the Department of Endocrinology and Metabolic Diseases of the Chu-Larrey Hospital.
It is noted that the extravalic manifestations of coronavirus infection may include endocrine forms, including pancreatic diseases, pituitary glands, gonad and thyroid.
So, scientists reported a significant frequency of subacute or chronic thyroiditis (inflammatory damage of the thyroid gland of various character), Hashimoto disease (chronic inflammatory disease of the thyroid gland autoimmune genesis) and other endocrine pathologies in patients with COVID-19.
Previously, scientists called the reasons for re-infection with coronavirus, revealing the immunity of COVID-19 to antibodies. This is due to natural compounds in the human body, which bind to the virus. British researchers from the Francis Creek Institute, the Imperial College of London, the Royal College of London and the University College of London, together with experts from Italy and the Netherlands, found that the hematoproteins – biliverdin and bilirubin include natural compounds that suppress antibody binding with spiker protexavirus protein. The authors of the study found that biliverdine by 30-50 percent suppresses the combination of human antibodies with a spike protein. As a result, they become ineffective in the fight against coronavirus.